首页 | 本学科首页   官方微博 | 高级检索  
     检索      


Aflatoxicosis chemoprevention by probiotic Lactobacillius and lack of effect on the major histocompatibility complex
Authors:Sumit Rawal  Miranda M Bauer  Kristelle M Mendoza  Hani El-Nezami  Jeffery R Hall  Ji Eun Kim  John R Stevens  Kent M Reed  Roger A Coulombe Jr
Institution:1. Graduate Toxicology Program, and Department of Animal, Dairy and Veterinary Sciences, Utah State University, Logan, UT 84322, USA;2. Department of Veterinary and Biomedical Sciences, College of Veterinary Medicine, University of Minnesota, St. Paul, MN 55108, USA;3. School of Biological Sciences, University of Hong Kong, Hong Kong, China;4. Department of Mathematics and Statistics, Utah State University, Logan, UT 84322, USA
Abstract:Turkeys are extremely sensitive to aflatoxin B1 (AFB1) which causes decreased growth, immunosuppression and liver necrosis. The purpose of this study was to determine whether probiotic Lactobacillus, shown to be protective in animal and clinical studies, would likewise confer protection in turkeys, which were treated for 11 days with either AFB1 (AFB; 1 ppm in diet), probiotic (PB; 1 × 1011 CFU/ml; oral, daily), probiotic + AFB1 (PBAFB), or PBS control (CNTL). The AFB1 induced drop in body and liver weights were restored to normal in CNTL and PBAFB groups. Hepatotoxicity markers were not significantly reduced by probiotic treatment. Major histocompatibility complex (MHC) genes BG1 and BG4, which are differentially expressed in liver and spleens, were not significantly affected by treatments. These data indicate modest protection, but the relatively high dietary AFB1 treatment, and the extreme sensitivity of this species may reveal limits of probiotic-based protection strategies.
Keywords:Gene expression  Aflatoxin  Chemoprevention  Toxicology  Probiotics  Turkeys  Poultry  MHC  BG
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号